Cover Image

Die Rolle des PSMA-PET/CT bei Patienten mit metastasiertem Prostatakarzinom = The role of PSMA PET-CT in patients with metastatic prostate cancer

Prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography (PET-CT) imaging for the localization of prostate cancer is increasingly available in Germany. The advances and limitations in different disease stages are reviewed. As the clinical relevance of oligometastati...

Full description

Saved in:
Bibliographic Details
Main Authors: Hardenberg, Jost von (Author) , Büsing, Karen-Anett (Author) , Nuhn, Philipp (Author) , Ritter, Manuel (Author)
Format: Article (Journal)
Language:German
Published: 17 January 2018
In: Der Radiologe
Year: 2018, Volume: 58, Issue: 3, Pages: 226-232
ISSN:1432-2102
DOI:10.1007/s00117-018-0358-8
Online Access:Verlag, Volltext: https://doi.org/10.1007/s00117-018-0358-8
Get full text
Author Notes:J. von Hardenberg, K.-A. Büsing, P. Nuhn, M. Ritter
Description
Summary:Prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography (PET-CT) imaging for the localization of prostate cancer is increasingly available in Germany. The advances and limitations in different disease stages are reviewed. As the clinical relevance of oligometastatic disease in primary cancer detected by PSMA PET-CT imaging is not yet completely understood, it should only be used in clinical trials. In recurrent prostate cancer after therapy with curative intent, PSMA PET-CT shows encouraging potential for the planning of salvage therapy. In metastatic castration-resistant prostate cancer evidence for its use is not available.
Item Description:Gesehen am 05.04.2019
Physical Description:Online Resource
ISSN:1432-2102
DOI:10.1007/s00117-018-0358-8

Similar Items